Bowhead Specialty Holdings (BOW) just wrapped up FY 2025 with Q4 total revenue of US$151.7 million and basic EPS of US$0.40, alongside trailing 12 month revenue of US$551.6 million and EPS of US$1.59 that sit against a one year earnings increase of 40.6%. Over recent quarters the company has seen revenue move from US$119.3 million in Q4 2024 to US$151.7 million in Q4 2025, while basic EPS shifted from US$0.42 to US$0.40. This sets up a picture where margins and profit efficiency are firmly in focus for investors reading this update.

See our full analysis for Bowhead Specialty Holdings.

With the latest numbers on the table, the next step is to see how this earnings profile lines up with the widely held narratives around Bowhead Specialty Holdings, and where the data might support or challenge those views.

Combined ratios trend toward mid 90s

• Across FY 2025, the combined ratio moved from 97.3% in Q1 to 95.4% in Q3, with prior year Q4 at 95.8%, while Q4 2025 did not disclose a combined ratio in the provided figures.
• Consensus narrative highlights disciplined underwriting and stable loss ratios as key strengths. This mid 90s combined ratio range aligns with that view but still leaves room for pressure if long tail claims or rising acquisition costs push the ratio higher.
  • Analysts point to a declining expense ratio toward a 30% area as an important driver, and a mid 90s combined ratio suggests that any setback in expense control or loss costs could quickly affect profitability.
  • At the same time, the reported net profit margin of 9.8% versus 9.0% a year earlier shows that, so far, underwriting discipline and efficiency gains are supporting the bullish idea of resilient profitability even as the book grows.

Investors who want to see how different views line up with these underwriting metrics can check how bulls and bears frame the story in more detail: 🐂 Bowhead Specialty Holdings Bull Case and 🐻 Bowhead Specialty Holdings Bear Case

Trailing earnings up 40.6% year on year

• On a trailing 12 month basis, net income reached US$53.8 million with EPS at US$1.59, compared with US$38.2 million and EPS of US$1.31 a year earlier, which corresponds to the 40.6% earnings growth noted in the summary.
• Supporters of the bullish narrative argue that strong growth in specialized lines and technology driven efficiency can sustain this kind of earnings profile, and the recent numbers give them some concrete support but also show where execution still matters.
  • Revenue on a trailing basis rose from US$425.7 million to US$551.6 million, and the net margin moved from 9.0% to 9.8%, which fits the bullish claim that scale and operational leverage are starting to show up in the income statement.
  • At the same time, quarterly EPS in FY 2025 ranged from US$0.35 to US$0.46, so while the full year and trailing figures look solid, the pattern reminds you that quarterly profitability can move around even when the longer trend looks supportive.

Premium P/E, yet below DCF fair value

• The shares trade on a trailing P/E of 14.8x, above both the US insurance industry at 12.3x and peers at 8.3x, while the current price of US$24.36 sits well below a DCF fair value estimate of about US$59.78 and an analyst target level of US$33.86.
• Critics in the bearish narrative focus on risks like social inflation, heavier exposure to long tail lines and rising competition, and the current premium P/E together with these risks helps explain why the market price may sit below the DCF fair value and analyst target, even with reported growth.
  • Forecasts calling for roughly 23.5% annual earnings growth and about 16% annual revenue growth make the P/E premium easier to understand, but they also raise the bar, because any slowdown in those figures could justify a lower multiple.
  • The net margin of 9.8% and trailing net income of US$53.8 million are the foundations of those growth and valuation views, so if claims costs or acquisition expenses rise, that would feed directly into the concerns bears have highlighted about future profitability.

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Bowhead Specialty Holdings on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

If the mix of optimism and caution in this article leaves you unsure, take a closer look yourself and form your own view fast, starting with 4 key rewards.

See What Else Is Out There

For all the growth in trailing earnings, the premium 14.8x P/E, quarterly EPS volatility and underwriting risks indicate that Bowhead’s risk and reward are finely balanced.

If you want alternatives where pricing might better reflect current fundamentals and risk, take a few minutes to review our 51 high quality undervalued stocks that could offer a more comfortable trade off.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.